Comparing survival outcomes for neoadjuvant therapy versus adjuvant therapy in the management of stage 1 pancreatic adenocarcinoma: A National Cancer Database study

Authors

Samit K. Datta, Advocate Aurora HealthFollow
Geoffrey Bellini, Advocate Aurora HealthFollow
Maharaj Singh, Advocate Aurora HealthFollow
Nicholas Sich, Advocate Aurora HealthFollow
James Weese, Advocate Aurora HealthFollow
Federico A. Sanchez, Advocate Aurora HealthFollow
Nalini Guda, Advocate Aurora Health
Wesley Papenfuss, Advocate Aurora HealthFollow
Aaron H. Chevinsky, Advocate Aurora HealthFollow

Recommended Citation

Datta SK, Bellini G, SIngh M, et al. Comparing survival outcomes for neoadjuvant therapy versus adjuvant therapy in the management of stage 1 pancreatic adenocarcinoma: A National Cancer Database study. Journal of Clinical Oncology. 2020;38(4S):664.

Affiliations

Aurora St. Luke's Medical Center

Aurora Cancer Care

Document Type

Abstract